ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
0.00
0.00
(0.00%)
終了 1月10日 6:00AM
0.00
0.00
(0.00%)
取引時間後: -

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
-
買値
-
売値
-
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
-
始値
-
時刻
最終取引時間
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

SNT 最新ニュース

Life Sciences Companies Webcast Live to Online Investors, July 12th, at RetailInvestorConferences.com

Life Sciences Companies Webcast Live to Online Investors, July 12th, at RetailInvestorConferences.com CEOs to take questions in real-time during formal roadshow presentations, meet and "chat" in...

NYSE Companies' and NASDAQ Companies' June 7th Investor Presentations Now Available at RetailInvestorConferences.com

NYSE Companies' and NASDAQ Companies' June 7th Investor Presentations Now Available at RetailInvestorConferences.com Free educational sessions: focus on biotech and healthcare stocks PR...

Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on June 7th

Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on June 7th Company invites Main Street and Wall Street investors to attend interactive real-time virtual...

NYSE Companies and NASDAQ Companies Meet to Webcast Live, June 7th, at RetailInvestorConferences.com

NYSE Companies and NASDAQ Companies Meet to Webcast Live, June 7th, at RetailInvestorConferences.com Free educational sessions: focus on biotech and healthcare stocks PR Newswire NEW YORK, June...

Senesco Provides SNS01-T Update on Phase 1b/2a Multiple Myeloma Trial

Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT) reported today on the progress of its Phase 1b/2a study for the treatment of multiple myeloma, which is...

Senesco’s SNS01-T to be Presented During Poster Session at 2012 Annual Meeting of the American Society of Clinical Oncology

Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT), announced today that a poster describing the ongoing SNS01-T study in multiple myeloma will be presented...

Senesco’s SNS01 is a Potent Regulator of Programmed Cell Death and Tumor Growth in Murine Models of Multiple Myeloma

Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT), announced today that the characteristics and activity of SNS01 have been released on-line in Molecular...

Senesco Technologies Reports Fiscal 2012 Third Quarter Results

Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE Amex: SNT) today reported financial results for the third quarter of fiscal year 2012 which ended on March 31...

Senesco to Present SNS01-T, an eIF5A-based Nanoparticle in a Phase 1b/2a Trial to Treat Multiple Myeloma, is Effective in Mod...

Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE Amex: SNT), announced today that an oral presentation will be delivered at the 15th Annual Meeting of the American...

Combination of Lenalidomide and SNS01-T Effective in Cancer Model

Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE AMEX: SNT) announced today that a high level of tumor eradication in a mouse model of human multiple myeloma was...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

SNT - Frequently Asked Questions (FAQ)

What is the current Senesco share price?
The current share price of Senesco is US$ 0.00
What is the 1 year trading range for Senesco share price?
Senesco has traded in the range of US$ 0.00 to US$ 0.00 during the past year

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AAPYKurv Yield Premium Strategy Apple AAPL ETF
US$ 26.5099
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
US$ 30.16
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
US$ 26.42
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
US$ 26.33
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
US$ 25.125
(0.00%)
0
AAPYKurv Yield Premium Strategy Apple AAPL ETF
US$ 26.5099
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
US$ 30.16
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
US$ 26.42
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
US$ 26.33
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
US$ 25.125
(0.00%)
0
AAPYKurv Yield Premium Strategy Apple AAPL ETF
US$ 26.5099
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
US$ 30.16
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
US$ 26.42
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
US$ 26.33
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
US$ 25.125
(0.00%)
0

最近閲覧した銘柄

Delayed Upgrade Clock